Xiaofeng Niu

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesCarbon capture engineering (excl. sequestration)Innate immunityGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2026
Dual modulation of lipid-lowering and anti-inflammatory effects of Thymus quinquecostatus Celak. ethanol extract on atherosclerosis: integration of UPLC-Q-TOF-MS/MS, in silico, in vivo, and in vitro studies.

|Jun 18, 2026
Yam glycoprotein mediated the immunomodulation of macrophages by targeting TLR4.

|Feb 14, 2023
(-)-Epicatechin gallate blocked cellular foam formation in atherosclerosis by modulating CD36 expression in vitro and in vivo.

Jinjin Yu, Lili Zhou, Huixin Song

|Mar 21, 2022
Schisandrin improves lipopolysaccharide-induced acute lung injury by inhibiting the inflammatory response in vivo and in vitro.

Weifeng Li, Qiuxia Huang, Jinjin Yu

|Aug 08, 2021
(-)-Epicatechin gallate blocks the development of atherosclerosis by regulating oxidative stress in vivo and in vitro.

Jinjin Yu, Weifeng Li, Xin Xiao

|Dec 22, 2020
Poria cocos polysaccharides reduces high-fat diet-induced arteriosclerosis in ApoE-/- mice by inhibiting inflammation.

Weifeng Li, Jinjin Yu, Jinmeng Zhao

Pageof 2

Frequent Collaborators

2 joint publications

Weifeng Li

2 joint publications

Huixin Song

1 joint publications

Yuzhi Luo

1 joint publications

Siqi Wang